Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B. European Concerted Action on Viral Hepatitis (Eurohep)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Natural History of Histologically-proven Alcohol Related Liver Disease: A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Clinical translatability of a diet-induced obese mouse model of non-alcoholic steatohepatitis

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

  3. HCV genotype 1-6 NS3 residue 80 substitutions impact protease inhibitor activity and promote viral escape

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Incidence of Hepatocellular Carcinoma in HIV/HBV-coinfected Patients on Tenofovir therapy: Relevance for Screening Strategies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Cirrhotic cardiomyopathy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Incidence and clinical presentation of groin injuries in sub-elite male soccer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Exercise program for prevention of groin pain in football players: a cluster-randomized trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Administrativ organisation og ansvar

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Presence and significance of TT virus in Danish patients on maintenance hemodialysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • K Krogsgaard
  • E Christensen
  • N Bindslev
  • S Schalm
  • P K Andersen
  • H Ring-Larsen
Vis graf over relationer
Alpha interferon (IFN) is an established treatment of chronic hepatitis B. The effect has been shown to be dose related, recommended dose regimens being associated with a doubling of the spontaneous, baseline HBeAg to anti-HBe seroconversion rate. However, the efficacy of IFN treatment in relation to the dose of IFN actually received remains to be established. The aim of this study was to estimate the relative efficacy of IFN as a function of the cumulative IFN dose. In addition we determined if and when a patient returns to his baseline chance of seroconversion after stopping IFN therapy.
OriginalsprogEngelsk
TidsskriftJournal of Hepatology
Vol/bind25
Udgave nummer6
Sider (fra-til)795-802
Antal sider8
ISSN0168-8278
DOI
StatusUdgivet - dec. 1996

ID: 38976875